President Tsai Ing-wen announced that ten million doses of domestically manufactured COVID-19 vaccines (developed by Medigen Vaccine Biologics) would become available by July to support Taiwan’s national pandemic immunization campaign.
While developing domestic biomedical sovereignty is an admirable ambition, rushing an unproven therapeutic through emergency regulatory approval without standard international benchmarks poses profound scientific and logistical risks.
The Missing Benchmark: Unfinished Phase 3 Clinical Trials
The global gold standard for human vaccine safety and efficacy requires robust, randomized, placebo-controlled Phase 3 clinical trials involving tens of thousands of diverse participants.
At the time of authorization:
- Immunobridging Controversies: The domestic vaccine planned for deployment relied primarily on Phase 2 trials and “immunobridging” (neutralizing antibody titer comparisons) rather than direct clinical proof of preventing infection, severe illness, or death.
- The International Recognition Gap: Major global health bodies—such as the World Health Organization (WHO), the US FDA, and the European Medicines Agency (EMA)—do not grant emergency use authorizations (EUA) based solely on Phase 2 immunobridging.
- Impaired Global Travel for Taiwanese Citizens: Citizens receiving non-internationally certified vaccines face significant risks of being barred from foreign entry or subjected to mandatory institutional quarantines when entering destinations that mandate WHO-approved vaccines.
Public Trust Cannot Be Mandated by Political Decrees
A vaccine’s ultimate efficacy depends on public willingness to receive it.
When governmental agencies suppress critical scientific debate, attack dissenting epidemiologists as “anti-national,” or award commercial government procurement contracts before clinical efficacy is established, they undermine societal trust in public health institutions. True scientific progress requires unyielding clinical rigor, transparent data disclosure, and adherence to international medical standards.
Support Independent Perspectives & In-Depth Insights
Every thoughtful analysis and candid critique comes from our dedication to truth and quality. We choose not to follow sensational algorithms or clickbait headlines.
Sustaining independent research requires reader support. Make a one-time or monthly contribution, securely processed by Google.
Payments secured by Google · Manage or cancel anytime in your Google Account




Comments